NCT00131651View on ClinicalTrials.gov

ATN-161 in Advanced Renal Cell Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2005

Conditions
Carcinoma, Renal Cell
Interventions
DRUG

ATN-161

Trial Locations (4)

44165

The Cleveland Clinic Foundation, Cleveland

92868

University of California Irvine, Chao Family Comprehensive Cancer Center, Irvine

94115

University of California San Francisco Comprehensive Cancer Center, San Francisco

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

Sponsors

Lead Sponsor

Attenuon
All Listed Sponsors
lead

Attenuon

INDUSTRY